Umoja seeks innovative strategic partners and licensing opportunities that leverage and complement our core technology platforms, internal capabilities, and expertise in generating curative therapies for solid tumor and blood cancers. If you are a compassionate, creative, solution-oriented partner who is invested in our mission to expand the benefits of our CAR T-cell gene therapy platform to patients in need, we look forward to hearing from you.